Home > > > Report Detail

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Ankylosing Spondylitis Drug Market 2018, Forecast to 2023

Publisher Name :
Date: 03-Jan-2019
No. of pages: 132

Ankylosing spondylitis is a form of chronic inflammation of the spine and the sacroiliac joints.

Scope of the Report:

This report focuses on the Ankylosing Spondylitis Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Ankylosing Spondylitis Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Amgen

- Wyeth

- Takeda

- Centocor

- Schering-Plough

- Mitsubishi Tanabe

- Abbott

- Eisai

- Pfizer

- Johnson & Johnson

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Cimzia

- Enbrel

- Humira

- Remicade

- Simponi

- Others

Market Segment by Applications, can be divided into

- Hospitals

- Clinics

There are 15 Chapters to deeply display the global Ankylosing Spondylitis Drug market.

Chapter 1, to describe Ankylosing Spondylitis Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Ankylosing Spondylitis Drug, with sales, revenue, and price of Ankylosing Spondylitis Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Ankylosing Spondylitis Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Ankylosing Spondylitis Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Ankylosing Spondylitis Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Ankylosing Spondylitis Drug Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Ankylosing Spondylitis Drug Introduction
1.2 Market Analysis by Type
1.2.1 Cimzia
1.2.2 Enbrel
1.2.3 Humira
1.2.4 Remicade
1.2.5 Simponi
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.1.1 Amgen Description
2.1.1.2 Amgen Headquarter, Main Business and Finance Overview
2.1.2 Amgen Ankylosing Spondylitis Drug Product Introduction
2.1.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
2.1.2.2 Ankylosing Spondylitis Drug Product Information
2.1.3 Amgen Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Amgen Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Amgen Ankylosing Spondylitis Drug Market Share in 2017
2.2 Wyeth
2.2.1 Business Overview
2.2.1.1 Wyeth Description
2.2.1.2 Wyeth Headquarter, Main Business and Finance Overview
2.2.2 Wyeth Ankylosing Spondylitis Drug Product Introduction
2.2.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
2.2.2.2 Ankylosing Spondylitis Drug Product Information
2.2.3 Wyeth Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Wyeth Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Wyeth Ankylosing Spondylitis Drug Market Share in 2017
2.3 Takeda
2.3.1 Business Overview
2.3.1.1 Takeda Description
2.3.1.2 Takeda Headquarter, Main Business and Finance Overview
2.3.2 Takeda Ankylosing Spondylitis Drug Product Introduction
2.3.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
2.3.2.2 Ankylosing Spondylitis Drug Product Information
2.3.3 Takeda Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Takeda Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Takeda Ankylosing Spondylitis Drug Market Share in 2017
2.4 Centocor
2.4.1 Business Overview
2.4.1.1 Centocor Description
2.4.1.2 Centocor Headquarter, Main Business and Finance Overview
2.4.2 Centocor Ankylosing Spondylitis Drug Product Introduction
2.4.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
2.4.2.2 Ankylosing Spondylitis Drug Product Information
2.4.3 Centocor Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Centocor Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Centocor Ankylosing Spondylitis Drug Market Share in 2017
2.5 Schering-Plough
2.5.1 Business Overview
2.5.1.1 Schering-Plough Description
2.5.1.2 Schering-Plough Headquarter, Main Business and Finance Overview
2.5.2 Schering-Plough Ankylosing Spondylitis Drug Product Introduction
2.5.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
2.5.2.2 Ankylosing Spondylitis Drug Product Information
2.5.3 Schering-Plough Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Schering-Plough Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Schering-Plough Ankylosing Spondylitis Drug Market Share in 2017
2.6 Mitsubishi Tanabe
2.6.1 Business Overview
2.6.1.1 Mitsubishi Tanabe Description
2.6.1.2 Mitsubishi Tanabe Headquarter, Main Business and Finance Overview
2.6.2 Mitsubishi Tanabe Ankylosing Spondylitis Drug Product Introduction
2.6.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
2.6.2.2 Ankylosing Spondylitis Drug Product Information
2.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Mitsubishi Tanabe Ankylosing Spondylitis Drug Market Share in 2017
2.7 Abbott
2.7.1 Business Overview
2.7.1.1 Abbott Description
2.7.1.2 Abbott Headquarter, Main Business and Finance Overview
2.7.2 Abbott Ankylosing Spondylitis Drug Product Introduction
2.7.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
2.7.2.2 Ankylosing Spondylitis Drug Product Information
2.7.3 Abbott Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Abbott Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Abbott Ankylosing Spondylitis Drug Market Share in 2017
2.8 Eisai
2.8.1 Business Overview
2.8.1.1 Eisai Description
2.8.1.2 Eisai Headquarter, Main Business and Finance Overview
2.8.2 Eisai Ankylosing Spondylitis Drug Product Introduction
2.8.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
2.8.2.2 Ankylosing Spondylitis Drug Product Information
2.8.3 Eisai Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Eisai Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Eisai Ankylosing Spondylitis Drug Market Share in 2017
2.9 Pfizer
2.9.1 Business Overview
2.9.1.1 Pfizer Description
2.9.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.9.2 Pfizer Ankylosing Spondylitis Drug Product Introduction
2.9.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
2.9.2.2 Ankylosing Spondylitis Drug Product Information
2.9.3 Pfizer Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Pfizer Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Pfizer Ankylosing Spondylitis Drug Market Share in 2017
2.10 Johnson & Johnson
2.10.1 Business Overview
2.10.1.1 Johnson & Johnson Description
2.10.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.10.2 Johnson & Johnson Ankylosing Spondylitis Drug Product Introduction
2.10.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
2.10.2.2 Ankylosing Spondylitis Drug Product Information
2.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Johnson & Johnson Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Johnson & Johnson Ankylosing Spondylitis Drug Market Share in 2017
3 Global Ankylosing Spondylitis Drug Market Competition, by Manufacturer
3.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Ankylosing Spondylitis Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Ankylosing Spondylitis Drug Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Ankylosing Spondylitis Drug Manufacturer Market Share in 2017
3.4.2 Top 5 Ankylosing Spondylitis Drug Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Ankylosing Spondylitis Drug Market Analysis by Regions
4.1 Global Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Ankylosing Spondylitis Drug Sales by Regions (2013-2018)
4.1.2 Global Ankylosing Spondylitis Drug Revenue by Regions (2013-2018)
4.2 North America Ankylosing Spondylitis Drug Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Ankylosing Spondylitis Drug Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Ankylosing Spondylitis Drug Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Ankylosing Spondylitis Drug Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Ankylosing Spondylitis Drug Sales, Revenue and Growth Rate (2013-2018)
5 North America Ankylosing Spondylitis Drug by Countries, Type, Application and Manufacturers
5.1 North America Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Ankylosing Spondylitis Drug Sales by Countries (2013-2018)
5.1.2 North America Ankylosing Spondylitis Drug Revenue by Countries (2013-2018)
5.1.3 United States Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
5.1.4 Canada Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
5.1.5 Mexico Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
5.2 North America Ankylosing Spondylitis Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Ankylosing Spondylitis Drug Sales by Manufacturers (2016-2017)
5.2.2 North America Ankylosing Spondylitis Drug Revenue by Manufacturers (2016-2017)
5.3 North America Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Ankylosing Spondylitis Drug Sales and Sales Share by Type (2013-2018)
5.3.2 North America Ankylosing Spondylitis Drug Revenue and Revenue Share by Type (2013-2018)
5.4 North America Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Ankylosing Spondylitis Drug Sales and Sales Share by Application (2013-2018)
5.4.2 North America Ankylosing Spondylitis Drug Revenue and Revenue Share by Application (2013-2018)
6 Europe Ankylosing Spondylitis Drug by Countries, Type, Application and Manufacturers
6.1 Europe Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Ankylosing Spondylitis Drug Sales by Countries (2013-2018)
6.1.2 Europe Ankylosing Spondylitis Drug Revenue by Countries (2013-2018)
6.1.3 Germany Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
6.1.4 UK Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
6.1.5 France Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
6.1.6 Russia Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
6.1.7 Italy Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
6.2 Europe Ankylosing Spondylitis Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Ankylosing Spondylitis Drug Sales by Manufacturers (2016-2017)
6.2.2 Europe Ankylosing Spondylitis Drug Revenue by Manufacturers (2016-2017)
6.3 Europe Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Ankylosing Spondylitis Drug Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Ankylosing Spondylitis Drug Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Ankylosing Spondylitis Drug Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Ankylosing Spondylitis Drug Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Ankylosing Spondylitis Drug by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Ankylosing Spondylitis Drug Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Ankylosing Spondylitis Drug Revenue by Countries (2013-2018)
7.1.3 China Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
7.1.4 Japan Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
7.1.5 Korea Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
7.1.6 India Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Ankylosing Spondylitis Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Ankylosing Spondylitis Drug Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Ankylosing Spondylitis Drug Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Ankylosing Spondylitis Drug Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Ankylosing Spondylitis Drug Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Ankylosing Spondylitis Drug Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Ankylosing Spondylitis Drug Revenue and Revenue Share by Application (2013-2018)
8 South America Ankylosing Spondylitis Drug by Countries, Type, Application and Manufacturers
8.1 South America Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Ankylosing Spondylitis Drug Sales by Countries (2013-2018)
8.1.2 South America Ankylosing Spondylitis Drug Revenue by Countries (2013-2018)
8.1.3 Brazil Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
8.1.4 Argentina Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
8.1.5 Colombia Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
8.2 South America Ankylosing Spondylitis Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Ankylosing Spondylitis Drug Sales by Manufacturers (2016-2017)
8.2.2 South America Ankylosing Spondylitis Drug Revenue by Manufacturers (2016-2017)
8.3 South America Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Ankylosing Spondylitis Drug Sales and Sales Share by Type (2013-2018)
8.3.2 South America Ankylosing Spondylitis Drug Revenue and Revenue Share by Type (2013-2018)
8.4 South America Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Ankylosing Spondylitis Drug Sales and Sales Share by Application (2013-2018)
8.4.2 South America Ankylosing Spondylitis Drug Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Ankylosing Spondylitis Drug by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Ankylosing Spondylitis Drug Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Ankylosing Spondylitis Drug Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
9.1.4 UAE Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
9.1.5 Egypt Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
9.1.7 South Africa Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Ankylosing Spondylitis Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Ankylosing Spondylitis Drug Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Ankylosing Spondylitis Drug Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Ankylosing Spondylitis Drug Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Ankylosing Spondylitis Drug Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Ankylosing Spondylitis Drug Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Ankylosing Spondylitis Drug Revenue and Revenue Share by Application (2013-2018)
10 Global Ankylosing Spondylitis Drug Market Segment by Type
10.1 Global Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Ankylosing Spondylitis Drug Revenue and Market Share by Type (2013-2018)
10.2 Cimzia Sales Growth and Price
10.2.1 Global Cimzia Sales Growth (2013-2018)
10.2.2 Global Cimzia Price (2013-2018)
10.3 Enbrel Sales Growth and Price
10.3.1 Global Enbrel Sales Growth (2013-2018)
10.3.2 Global Enbrel Price (2013-2018)
10.4 Humira Sales Growth and Price
10.4.1 Global Humira Sales Growth (2013-2018)
10.4.2 Global Humira Price (2013-2018)
10.5 Remicade Sales Growth and Price
10.5.1 Global Remicade Sales Growth (2013-2018)
10.5.2 Global Remicade Price (2013-2018)
10.6 Simponi Sales Growth and Price
10.6.1 Global Simponi Sales Growth (2013-2018)
10.6.2 Global Simponi Price (2013-2018)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2013-2018)
10.7.2 Global Others Price (2013-2018)
11 Global Ankylosing Spondylitis Drug Market Segment by Application
11.1 Global Ankylosing Spondylitis Drug Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
12 Ankylosing Spondylitis Drug Market Forecast (2018-2023)
12.1 Global Ankylosing Spondylitis Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Ankylosing Spondylitis Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Ankylosing Spondylitis Drug Market Forecast (2018-2023)
12.2.2 Europe Ankylosing Spondylitis Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Ankylosing Spondylitis Drug Market Forecast (2018-2023)
12.2.4 South America Ankylosing Spondylitis Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Ankylosing Spondylitis Drug Market Forecast (2018-2023)
12.3 Ankylosing Spondylitis Drug Market Forecast by Type (2018-2023)
12.3.1 Global Ankylosing Spondylitis Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Ankylosing Spondylitis Drug Market Share Forecast by Type (2018-2023)
12.4 Ankylosing Spondylitis Drug Market Forecast by Application (2018-2023)
12.4.1 Global Ankylosing Spondylitis Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Ankylosing Spondylitis Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Ankylosing Spondylitis Drug Picture
Table Product Specifications of Ankylosing Spondylitis Drug
Figure Global Ankylosing Spondylitis Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Ankylosing Spondylitis Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Ankylosing Spondylitis Drug by Types in 2017
Figure Cimzia Picture
Table Major Manufacturers of Cimzia
Figure Enbrel Picture
Table Major Manufacturers of Enbrel
Figure Humira Picture
Table Major Manufacturers of Humira
Figure Remicade Picture
Table Major Manufacturers of Remicade
Figure Simponi Picture
Table Major Manufacturers of Simponi
Figure Others Picture
Table Major Manufacturers of Others
Figure Ankylosing Spondylitis Drug Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure United States Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Ankylosing Spondylitis Drug Revenue (Value) and Growth Rate (2013-2023)
Table Amgen Headquarter, Established, Main Business and Finance Overview (2017)
Table Amgen Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
Table Amgen Ankylosing Spondylitis Drug Product
Table Amgen Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amgen Ankylosing Spondylitis Drug Sales Market Share in 2017
Figure Global Amgen Ankylosing Spondylitis Drug Revenue Market Share in 2017
Table Wyeth Headquarter, Established, Main Business and Finance Overview (2017)
Table Wyeth Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
Table Wyeth Ankylosing Spondylitis Drug Product
Table Wyeth Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Wyeth Ankylosing Spondylitis Drug Sales Market Share in 2017
Figure Global Wyeth Ankylosing Spondylitis Drug Revenue Market Share in 2017
Table Takeda Headquarter, Established, Main Business and Finance Overview (2017)
Table Takeda Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
Table Takeda Ankylosing Spondylitis Drug Product
Table Takeda Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Takeda Ankylosing Spondylitis Drug Sales Market Share in 2017
Figure Global Takeda Ankylosing Spondylitis Drug Revenue Market Share in 2017
Table Centocor Headquarter, Established, Main Business and Finance Overview (2017)
Table Centocor Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
Table Centocor Ankylosing Spondylitis Drug Product
Table Centocor Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Centocor Ankylosing Spondylitis Drug Sales Market Share in 2017
Figure Global Centocor Ankylosing Spondylitis Drug Revenue Market Share in 2017
Table Schering-Plough Headquarter, Established, Main Business and Finance Overview (2017)
Table Schering-Plough Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
Table Schering-Plough Ankylosing Spondylitis Drug Product
Table Schering-Plough Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Schering-Plough Ankylosing Spondylitis Drug Sales Market Share in 2017
Figure Global Schering-Plough Ankylosing Spondylitis Drug Revenue Market Share in 2017
Table Mitsubishi Tanabe Headquarter, Established, Main Business and Finance Overview (2017)
Table Mitsubishi Tanabe Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
Table Mitsubishi Tanabe Ankylosing Spondylitis Drug Product
Table Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales Market Share in 2017
Figure Global Mitsubishi Tanabe Ankylosing Spondylitis Drug Revenue Market Share in 2017
Table Abbott Headquarter, Established, Main Business and Finance Overview (2017)
Table Abbott Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
Table Abbott Ankylosing Spondylitis Drug Product
Table Abbott Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Abbott Ankylosing Spondylitis Drug Sales Market Share in 2017
Figure Global Abbott Ankylosing Spondylitis Drug Revenue Market Share in 2017
Table Eisai Headquarter, Established, Main Business and Finance Overview (2017)
Table Eisai Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
Table Eisai Ankylosing Spondylitis Drug Product
Table Eisai Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eisai Ankylosing Spondylitis Drug Sales Market Share in 2017
Figure Global Eisai Ankylosing Spondylitis Drug Revenue Market Share in 2017
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
Table Pfizer Ankylosing Spondylitis Drug Product
Table Pfizer Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Ankylosing Spondylitis Drug Sales Market Share in 2017
Figure Global Pfizer Ankylosing Spondylitis Drug Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Ankylosing Spondylitis Drug Product
Table Johnson & Johnson Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Ankylosing Spondylitis Drug Sales Market Share in 2017
Figure Global Johnson & Johnson Ankylosing Spondylitis Drug Revenue Market Share in 2017
Table Global Ankylosing Spondylitis Drug Sales by Manufacturer (2016-2017)
Figure Global Ankylosing Spondylitis Drug Sales Market Share by Manufacturer in 2016
Figure Global Ankylosing Spondylitis Drug Sales Market Share by Manufacturer in 2017
Table Global Ankylosing Spondylitis Drug Revenue by Manufacturer (2016-2017)
Figure Global Ankylosing Spondylitis Drug Revenue Market Share by Manufacturer in 2016
Figure Global Ankylosing Spondylitis Drug Revenue Market Share by Manufacturer in 2017
Table Global Ankylosing Spondylitis Drug Price by Manufacturer (2016-2017)
Figure Top 3 Ankylosing Spondylitis Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Ankylosing Spondylitis Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
Figure Global Ankylosing Spondylitis Drug Revenue and Growth Rate (2013-2018)
Table Global Ankylosing Spondylitis Drug Sales by Regions (2013-2018)
Table Global Ankylosing Spondylitis Drug Sales Market Share by Regions (2013-2018)
Table Global Ankylosing Spondylitis Drug Revenue by Regions (2013-2018)
Figure Global Ankylosing Spondylitis Drug Revenue Market Share by Regions in 2013
Figure Global Ankylosing Spondylitis Drug Revenue Market Share by Regions in 2017
Figure North America Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
Figure North America Ankylosing Spondylitis Drug Revenue and Growth Rate (2013-2018)
Figure Europe Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
Figure Europe Ankylosing Spondylitis Drug Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Ankylosing Spondylitis Drug Revenue and Growth Rate (2013-2018)
Figure South America Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
Figure South America Ankylosing Spondylitis Drug Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Ankylosing Spondylitis Drug Revenue and Growth Rate (2013-2018)
Figure North America Ankylosing Spondylitis Drug Revenue and Growth Rate (2013-2018)
Table North America Ankylosing Spondylitis Drug Sales by Countries (2013-2018)
Table North America Ankylosing Spondylitis Drug Sales Market Share by Countries (2013-2018)
Figure North America Ankylosing Spondylitis Drug Sales Market Share by Countries in 2013
Figure North America Ankylosing Spondylitis Drug Sales Market Share by Countries in 2017
Table North America Ankylosing Spondylitis Drug Revenue by Countries (2013-2018)
Table North America Ankylosing Spondylitis Drug Revenue Market Share by Countries (2013-2018)
Figure North America Ankylosing Spondylitis Drug Revenue Market Share by Countries in 2013
Figure North America Ankylosing Spondylitis Drug Revenue Market Share by Countries in 2017
Figure United States Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
Figure Canada Ankylosing Spondylit
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs